During the past decade, Hôpital Archet 1/Service d'Hématologie Clinique conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Archet 1/Service d'Hématologie Clinique" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "BerGenBio ASA" with 1 trials as a collaborator, "Groupe Francophone des Myelodysplasies" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Archet 1/Service d'Hématologie Clinique" are "Acute Myeloid Leukemia" (3 trials), "Myelodysplastic Syndromes" (2 trials), "High-risk Myelodysplastic Syndrome" (1 trials), "Leukemia Acute Myeloid" (1 trials) and "Low-risk Myelodysplastic Syndrome" (1 trials). Many other conditions were trialed in "Hôpital Archet 1/Service d'Hématologie Clinique" in a lesser frequency.

Most popular intervention types in "Hôpital Archet 1/Service d'Hématologie Clinique" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "AG-120" (1 trials), "AG-221" (1 trials), "Bemcentinib" (1 trials), "Lomustine" (1 trials) and "Reduced_intensity conditioning" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Archet 1/Service d'Hématologie Clinique" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Archet 1/Service d'Hématologie Clinique". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital Archet 1/Service d'Hématologie Clinique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Archet 1/Service d'Hématologie Clinique, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".